SynthesisFrontiers in immunology2025

Efficacy and safety of PD-1/PD-L1 inhibitors alone or in combination in the treatment of metastatic or advanced renal cell carcinoma: a network meta-analysis.

Dongli Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.